Enliven Therapeutics increased its research and development spending in the fourth quarter of fiscal 2024 as several drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback